Novo Nordisk hits back at copycat drugs

Gilts rebounded from earlier losses on Monday afternoon, and Novo Nordisk is suing US telehealth company Hims & Hers over ‘knock-off’ versions of its weight-loss drugs. Plus, France’s central bank chief is stepping down early, and US senators are pushing proposals to lift bank deposit insurance limits to avoid another Silicon Valley Bank debacle. Mentioned in this podcast:Gilts stabilise after cabinet voices support for Keir StarmerNovo Nordisk sues Hims & Hers over copycat weight-loss drugsNovo Nordisk faces more gloom from price cuts in crowded anti-obesity drugs marketFrench central bank governor to step down earlyCan the US crack the formula for ending bank runs?Note: The FT does not use generative AI to voice its podcasts Today’s FT News Briefing was hosted and produced by Sonja Hutson. Our show was mixed by Kelly Garry. Additional help from Gavin Kallmann, Michael Lello and David da Silva. Our executive producer is Topher Forhecz. Cheryl Brumley is the FT’s Global Head of Audio. The show’s theme music is by Metaphor Music.Read a transcript of this episode on FT.com Hosted on Acast. See acast.com/privacy for more information.